Genentech, Inc.
All Topics
Find news about people
Find news on alumni of any org
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions


Change Feed

News on Genentech, Inc.

... Inc. 15.20 Immune Pharmaceuticals 15.19 Heron Therapeutics 15.18 Gilead Sciences Inc. 15.17 Genentech Inc. 15.16 Galapagos NV 15.15 Eli Lilly & Company 15.14 Egalet Corporation ...
... limited than current market valuations. The monoclonal antibody DMTs, specifically Biogen's Tysabri, Genentech's Ocrevus and off label Rituxan, and Genzyme's Lemtrada, are considered high-efficacy DMTs ...
... Genentech, a division of Roche Holding AG , is using virtual reality as ...
... Genentech has paid $120 million upfront to secure global rights to IL-15 cytokine ...
... compared with placebo in patients with late window acute ischemic stroke (AIS). Genentech, a member of the Roche Group, sponsored the study. Stroke is the ...
... people with inherited bleeding disorders in developing countries. Together with Chugai and Genentech, members of the Roche Group, Roche's commitment to the WFH Program consists ...
... Evolus had established for manufacturing it. RELATED: Citing 'brazen' trade secrets theft, Genentech sues indicted ex-employees and biosim maker According to notes to clients by ...
... today announced it has entered into a research and license agreement with Genentech, a member of the Roche Group, to develop and commercialize novel IL-15 ...
... the combination of BL-8040 and KEYTRUDA® (pembrolizumab), and a collaboration agreement with Genentech Inc., a member of the Roche Group, to investigate the combination of ...
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/News/genentech-inc-o6519
  • https://relationshipscience.com/News/genentech-inc-o6519
Subscribe now for full coverage on Genentech, Inc.
Start My Free Trial